-
June 16, 2022 The Four Psychedelics ETFs Capturing Investor AttentionDespite an overarching shared thesis, the four psychedelics ETFs differ in philosophy, strategy, execution, and...
-
June 15, 2022 Examining Ketamine Therapy with Myriam Barthes, Journey ClinicalIn today’s episode, Myriam describes the impact of ketamine on the mind and the body,...
-
June 14, 2022 Encountering DMT Entities: Are they Real?DMT is a powerful hallucinogen famous for producing experiences of encounters with entities, but how...
-
June 13, 2022 Sol Psychedelphia – A Psychedelics Community Education Event“This event wisely explores and intentionally focuses on living better through evidence-based science and the...
-
June 10, 2022 Psychedelic Business Spotlight – June 10This week in psychedelic business news: Cybin acquires a Phase 1 DMT trial from Entheon;...
-
June 8, 2022 Can Psychedelics Improve Scientific Creativity?Scientific discovery comes from creative insights, and a recently published review details how psychedelics can...
-
June 8, 2022 The History of LSD: A Story of Self-ExperimentationDespite the LSD experience lasting only two hours, Hofmann was amazed at the power of...
-
May 31, 2022 British Columbia to Decriminalize Possession of Most DrugsThose caught with under 2.5 grams of illicit drugs, including heroin and fentanyl, will not...
-
May 21, 2022 Senator’s Wife Secretly Gave Him Psilocybin to Alleviate DepressionSenator Larry Campbell, who struggles with depression, PTSD, and “getting old," reveals that psilocybin microdoses...
-
May 12, 2022 Interview with Sam Chapman, Executive Director of the Healing Advocacy FundThis week on the Psychedelic Spotlight podcast, we talk with Sam Chapman. Sam is a...
